Image from Google Jackets
Image from OpenLibrary

Children and Drug Safety : Balancing Risk and Protection in Twentieth-Century America / Cynthia A Connolly.

By: Material type: TextTextLanguage: English Series: Critical Issues in Health and MedicinePublisher: New Brunswick, NJ : Rutgers University Press, [2018]Copyright date: ©2018Description: 1 online resource (260 p.) : 8Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9780813563893
Subject(s): Additional physical formats: No titleDDC classification:
  • 615.1083 23
LOC classification:
  • RJ560 .C66 2018
  • RJ560 .C66 2018
Online resources:
Contents:
Frontmatter -- Contents -- 1. Drug Therapy: From "Baby Killers" to Baby Savers, 1906-1933 -- 2. New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933-1945 -- 3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945-1961 -- 4. The Growth and Development of the Therapeutic Orphan, 1961-1979 -- 5. A "Big Business Built for Little Customers": Candy Aspirin, Children, and Poisoning, 1947-1976 -- 6. Children and Psychopharmacology in Postwar America -- 7. Pediatric Drug Development and Policy after 1979 -- Appendix -- Acknowledgments -- Notes -- Index -- About the Author
Summary: Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance-many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children's risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable.
Tags from this library: No tags from this library for this title.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode
E-Book E-Book De Gruyter Available

Frontmatter -- Contents -- 1. Drug Therapy: From "Baby Killers" to Baby Savers, 1906-1933 -- 2. New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933-1945 -- 3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945-1961 -- 4. The Growth and Development of the Therapeutic Orphan, 1961-1979 -- 5. A "Big Business Built for Little Customers": Candy Aspirin, Children, and Poisoning, 1947-1976 -- 6. Children and Psychopharmacology in Postwar America -- 7. Pediatric Drug Development and Policy after 1979 -- Appendix -- Acknowledgments -- Notes -- Index -- About the Author

Open Access unrestricted online access star

https://purl.org/coar/access_right/c_abf2

Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance-many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children's risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable.

Mode of access: Internet via World Wide Web.

This eBook is made available Open Access under a CC BY-NC-ND 4.0 license:

https://creativecommons.org/licenses/by-nc-nd/4.0

https://www.degruyter.com/dg/page/open-access-policy

In English.

Description based on online resource; title from PDF title page (publisher's Web site, viewed 29. Jun 2022)

There are no comments on this title.

to post a comment.

University of Rizal System
Email us at univlibservices@urs.edu.ph

Visit our Website www.urs.edu.ph/library

Powered by Koha